ArticleBlood2021

Phase 1a/b study of monoclonal antibody CAEL-101 (11-1F4) in patients with AL amyloidosis.

Camille Vanessa Edwards et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.